NICHD Pelvic Floor Disorders Network
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, NICHD Pelvic Floor Disorders Network sits in the top decile of US sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count).
NICHD Pelvic Floor Disorders Network: 17 sponsored US clinical trials, 3 recruiting.
NICHD Pelvic Floor Disorders Network sponsors 17 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 12 completed. 6 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Pelvic Organ Prolapse, with 2 trials.
Top-decile sponsor footprint
NICHD Pelvic Floor Disorders Network ranks in the top decile of sponsors by registered trial count (#842 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
12 of 13 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
17 total, page 1 of 1
The AccelERate Trial
NCT07218016
Training for Urinary Leakage Improvement After Pregnancy
NCT06411158
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
NCT06480227
Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
NCT02676973
Sling vs Botox for Mixed Incontinence
NCT04171531
Neuromodulation for Accidental Bowel Leakage
NCT03278613
Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
NCT02008565
Combined Treatment for Mixed Incontinence
NCT01959347
Study of Uterine Prolapse Procedures - Randomized Trial
NCT01802281
Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
NCT01502956
Behavioral Therapy Of Obstetric Sphincter Tears
NCT01166399
The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study
NCT01166373
Anticholinergic vs. Botox Comparison Study
NCT01166438
Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
NCT00597935
Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
NCT00460434
ATLAS: Ambulatory Treatments for Leakage Associated With Stress
NCT00270998
Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse
NCT00099372
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 3 | 6 |
Therapeutic Areas
Where NICHD Pelvic Floor Disorders Network enrollment is open (later-stage tilt)
3 recruiting of 17 indexed (18% open); 12 completed (71%).
Phase mix: 6 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Pelvic Organ Prolapse (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NICHD Pelvic Floor Disorders Network: open-pipeline peers nationwide
Peers matched on 17 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
NICHD Pelvic Floor Disorders Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 17 trials (± recruiting share)
- Achieve Life Sciences · 17 trials · 0% recruiting
- BioDelivery Sciences International · 17 trials · 6% recruiting
- Chugai Pharmaceutical · 17 trials · 24% recruiting
- ConvaTec · 17 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- Sanford Health · 18% recruiting · 34 trials
- Woman's · 18% recruiting · 17 trials
Related
What to do with this NICHD Pelvic Floor Disorders Network page
17 registered trials is a research-attention snapshot, not an endorsement of NICHD Pelvic Floor Disorders Network or any single study.
- 3 of NICHD Pelvic Floor Disorders Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Pelvic Organ Prolapse is the condition NICHD Pelvic Floor Disorders Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pelvic Organ Prolapse trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NICHD Pelvic Floor Disorders Network pipeline card: 17 registered trials from official public datasets.Report a data error.